Stay updated with breaking news from Dror Bashan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Protalix BioTherapeutics (NYSE:PLX – Free Report) from a hold rating to a buy rating in a research report sent to investors on Thursday. PLX has been the topic of several other reports. TheStreet raised shares of Protalix BioTherapeutics from a d- rating to a c- rating in a report on Monday, […]
StockNews.com upgraded shares of Protalix BioTherapeutics (NYSE:PLX – Free Report) from a hold rating to a buy rating in a report published on Thursday. Several other research firms also recently commented on PLX. HC Wainwright reaffirmed a buy rating and set a $10.00 price objective on shares of Protalix BioTherapeutics in a research note on […]
Protalix BioTherapeutics (NYSE:PLX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Thursday. Several other analysts also recently commented on the stock. TheStreet upgraded shares of Protalix BioTherapeutics from a “d-” rating to a “c-” rating in a […]
Protalix BioTherapeutics, Inc. (NYSE:PLX – Free Report) – Stock analysts at HC Wainwright boosted their FY2023 EPS estimates for shares of Protalix BioTherapeutics in a note issued to investors on Tuesday, November 14th. HC Wainwright analyst R. Selvaraju now expects that the company will earn $0.16 per share for the year, up from their prior […]
Operator: Good morning, ladies and gentlemen. And welcome to the Protalix Biotherapeutics Third Quarter 2023 Financial and Business Results Conference Call.